8-K: BioAffinity Technologies to Present at H.C. Wainwright Conference

BioAffinity Technologies, Inc. announced it will present updated company materials at the H.C. Wainwright 27th Annual Global Investment Conference.

Summary

• BioAffinity Technologies, Inc. (BIAF) has prepared and furnished presentation materials (Exhibit 99.1) to the SEC.
• These materials are intended for use by management in presentations regarding the company's operations and performance.
• The company plans to use these materials at the H.C. Wainwright 27th Annual Global Investment Conference, scheduled from September 8, 2025, through September 10, 2025.
• The information provided in this Item 7.01 and Exhibit 99.1 is furnished under Regulation FD and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.

Sentiment

Score: 6

Explanation: The filing is largely administrative, announcing an upcoming conference presentation. While it doesn't contain new material financial data, the increased visibility from participating in a global investment conference is generally a positive for investor relations.

Positives

• Increased visibility for BioAffinity Technologies through participation in a global investment conference.
• Opportunity for management to communicate company operations and performance to a broader audience of investors and analysts.

Risks

• The information in this filing is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it is not subject to the same liabilities as 'filed' documents.

Future Outlook

Management intends to use the furnished presentation materials to discuss the company's operations and performance at upcoming investor events, including the H.C. Wainwright 27th Annual Global Investment Conference.

Industry Context

Participation in prominent investment conferences like the H.C. Wainwright Global Investment Conference is a standard practice for publicly traded companies, particularly in the biotechnology sector, to enhance investor relations, attract capital, and communicate strategic and operational updates to a global audience of investors and analysts.

Stakeholder Impact

• Shareholders: Potential for increased awareness and understanding of the company's operations and performance through the conference presentation.
• Investors: Provides access to updated company information via the furnished presentation materials, aiding in due diligence and investment decisions.

Next Steps

• Management will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, utilizing the furnished presentation materials.

Key Dates

Keywords

BioAffinity Technologies, H.C. Wainwright, Global Investment Conference, BIAF, BIAFW, Regulation FD, Investor Presentation, Biotechnology, Healthcare